Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172024 · ClinicalTrials.gov registry record
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 15,172
- Enrollment target
NCT05172024: Completed study, sponsored by NYU Langone Health.
NCT05172024 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 15,172 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172024 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 15,172 participants
- Enrollment target
Study Summary
This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without Post-Acute Sequelae of COVID-19 (PASC) symptoms will be followed to identify risk factors and occurrence of PASC. This study will be conducted in the United States and subjects will be recruited through inpatient, outpatient, and community-based settings. Study data including age, demographics, social determinants of health, medical history, vaccination history, details of acute SARS-CoV-2 infection, overall health and physical function, and PASC symptom screen will be reported by subjects or collected from the electronic health record using a case report form at specified intervals. Biologic specimens will be collected at specified intervals, with some tests performed in local clinical laboratories and others performed by centralized research centers or banked in the Biospecimen Repository. Advanced clinical examinations and radiologic examinations will be performed at local study sites with cross-site standardization.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,172 participants |
| Start Date | 2021-10-29 |
| Est. Completion | 2025-10-31 |
What the finished NCT05172024 record still lists
NCT05172024 is an observational study that tracks outcomes without assigning an intervention. Its 15,172 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05172024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05172024 about?
NCT05172024 is a clinical study titled "Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)". This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at varying stages before and after infection. Individuals with and without SARS-CoV-2 infection and with or without Post-Acute ...
What is the current status of trial NCT05172024?
This trial is currently completed. The enrollment target is 15,172 participants. The study started on 2021-10-29. Estimated completion is 2025-10-31.
Who is sponsoring clinical trial NCT05172024?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07000357 · 15,100 participants · Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI